Department of Medicine 3 – Rheumatology and Immunology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases (2021) Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, et al. Journal article, Review article A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, De La Rosa K, Tenbusch M, Schulz S, et al. Journal article Effects of Autoantibodies on Osteoclasts (2021) Sokolova M, Steffen U Journal article, Review article New Insights into Bone Loss in RA (2021) Andreev D, Bozec A Journal article, Review article Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE (2021) D'Agostino MA, Schett G, Lopez-Rdz A, Senolt L, Fazekas K, Burgos-Vargas R, Maldonado-Cocco J, et al. Journal article Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021) Behrens F, Leage SL, Sapin C, El Baou C, De La Torre I, Meszaros G, Schett G, et al. Journal article High Na+ Environments Impair Phagocyte Oxidase-Dependent Antibacterial Activity of Neutrophils (2021) Krampert L, Bauer K, Ebner S, Neubert P, Ossner T, Weigert A, Schatz V, et al. Journal article Enasidenib in IDH-2 mutant AML patients with relapse after allogeneic stem cell transplantation (2021) Vasova I, Spörl S, Guggenberger V, Berisha M, Rech D, Behzad A, Brandt A, et al. Conference contribution Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution